The Green Organic Dutchman Holdings Ltd. TGOD TGODF confirmed Tuesday it has completed its first commercial shipment of cannabis oils to the Australian medical cannabis market.
Last year, the producer of organically grown cannabis entered a distribution agreement with LeafCann for the Australian and New Zealand medical cannabis markets. Medicinal cannabis was federally legalized in Australia in 2016.
The Toronto-based TGOD noted that stability studies conducted by the company and LeafCann have revealed that the TGOD oils are reliable in their consistency and maintain their cannabinoid content.
The company plans to introduce more cannabis products to the Australian and New Zealand markets in 2022.
"This shipment to Australia is an important milestone for TGOD as it marks our entry into the Asia-Pacific market" Sean Bovingdon, TGOD's CEO and interim CFO stated.
Coming less than two months after its first shipment to South Africa, TGOD continues to lay the foundation for large-scale international market commercialization.
"We remain laser-focused on execution as we chart the course for future growth, including opportunities in international markets," added Bovingdon.
LeafCann CEO, Elisabetta Faenza said LeafCanna is thrilled to offer high-quality products at reasonable prices in Australia. “The Green Organic Dutchman's commitment to organic production is a real plus and a clear point of differentiation in the marketplace," Faenza added.
More recent news from TGOD:
The Green Organic Dutchman To Start Trading On CSE, Delists From TSX
The Green Organic Dutchman To Debut On CSE, Poised To Enter U.S. Cannabis Market
Green Organic Dutchman's Cannabis First To Be Distributed In South African Medical Marijuana Market
Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
Price Action
The Green Organic Dutchman’s shares were trading 0.30% lower at 14 cents per share at the time of writing Tuesday afternoon.
Photo: Courtesy of CNW Group/The Green Organic Dutchman Holdings Ltd.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.